Antihelminthic drug for T2DM therapy?

被引：1
|
作者：
Joana Osório
机构：
来源：
Nature Reviews Endocrinology | 2014年 / 10卷 / 12期
关键词：
D O I：
10.1038/nrendo.2014.183
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：702 / 702
相关论文
共 50 条
  • [31] Two drugs are better than one to start T2DM therapy
    Francesco Prattichizzo
    Lucia La Sala
    Antonio Ceriello
    Nature Reviews Endocrinology, 2020, 16 : 15 - 16
  • [32] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    DIABETES, 2013, 62 : A492 - A492
  • [33] Two drugs are better than one to start T2DM therapy
    Prattichizzo, Francesco
    La Sala, Lucia
    Ceriello, Antonio
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (01) : 15 - 16
  • [34] Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM
    Lavrynenko, Olga
    Alatrach, Mariam
    Abdul-Ghani, Muhammad
    Cersosimo, Eugenio
    Alkhouri, Naim
    Puckett, Curtiss L., Jr.
    Defronzo, Ralph A.
    Adams, John M., II
    Vasquez, Juan A., Jr.
    Clarke, Geoffrey D.
    DIABETES, 2020, 69
  • [35] Characteristics of Remission Patients with Newly Diagnosed T2DM in Intensive Therapy
    Wan, Xuesi
    Chen, Ailing
    Deng, Wanping
    Liu, Liehua
    Li, Hai
    Liu, Jianbin
    Fang, Donghong
    Guan, Hongyu
    Liang, Minhua
    Li, Yanbing
    DIABETES, 2011, 60 : A264 - A264
  • [36] Pioglitazone (PIO) improves glycemic control in drug-therapy naive patients with type 2 diabetes (T2DM)
    Herz, M
    Tan, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, L
    DIABETES, 2002, 51 : A481 - A481
  • [37] Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM)
    Tan, MH
    Herz, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    DIABETES, 2002, 51 : A497 - A497
  • [38] THERAPY Risk of metformin use in patients with T2DM and advanced CKD
    Schernthaner, Guntram
    Schernthaner-Reiter, Marie Helene
    NATURE REVIEWS ENDOCRINOLOGY, 2015, 11 (12) : 697 - 698
  • [39] T2DM treatment trial results
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 499 - 499
  • [40] Defining genetic risk of T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 438 - 438
12345